- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-19-0036478

About Crescent Labs Private Limited
Data last updated:
Crescent Labs Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the animal pharmaceuticals and healthcare segment of the pharmaceuticals sector. It was incorporated on 06 March 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24100MH2009PTC190787. Its GSTIN is 24AADCC6101E1ZD (Gujarat). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹50 Lakh. It is led by directors Vishal Rajendra Shah and Rajendra Kantilal Shah.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 15 Lalwani Industrial Estate 14 G D Ambekar Road Wadala, Mumbai, Maharashtra, India – 400031.
As per the financials filed for FY 2025, the company reported a revenue of ₹38.2 Cr, a decline of 8% compared to the previous year. For the same year it recorded a net profit of ₹2.33 Cr (net margin 6.1%) and EBITDA of ₹3.92 Cr (EBITDA margin 10.3%). Revenue has grown at a compounded annual rate (CAGR) of 7% over five years.
The company has about 50 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Crescent Labs. As per MCA filings, the company has satisfied charges of ₹3.55 Cr on record. Court records list 3 cases involving the company, including 3 filed against it.
Crescent Labs Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0036478). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website vibropharma.com.
Company details
Recognitions & Rankings of Crescent Labs
Contact details
Crescent Labs Private Limited's registered office is in Mumbai, Maharashtra. Its website is vibropharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address15 Lalwani Industrial Estate 14 G D Ambekar Road Wadala, Mumbai, Maharashtra, India – 400031
- IndustryPharma, Animal Pharmaceuticals & Healthcare
To see the full contact details of Crescent Labs Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Crescent Labs operates one associated brand: Crescent Labs. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Produces high-quality sterile injectable pharmaceutical products. | crescentlabs.in |
Business activity
The main business activity of Crescent Labs is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Crescent Labs Private Limited, buy the company report.
Financials of Crescent Labs Private Limited
FY 2024 filings availableCrescent Labs Private Limited reported revenue of ₹38.2 Cr (down 8% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 8% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 7%. EBITDA rose 4% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.92 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.33 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10.3% | ||||
| Net Profit Margin | 6.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Crescent Labs Private Limited, buy the company report.
Board of directors of Crescent Labs Private Limited
Crescent Labs has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vishal Rajendra Shah Also directs: Unisol Estate Private Limited, Vibro Pharma Private Limited | Director | 06 Mar 2009 | 17 Years 8 Months | Current |
| Rajendra Kantilal Shah Also directs: Unisol Estate Private Limited, Vibro Pharma Private Limited | Director | 06 Mar 2009 | 17 Years 8 Months | Current |
Peer comparison
Crescent Labs Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Animal Pharma), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| RR Animal Health Care Limited | ₹41.86 Cr (FY 2025) | 32.0% | Hyderabad, Telangana, India | |||
| Natural Living Private Limited | ₹41.39 Cr (FY 2025) | 72.0% | Bangalore, Karnataka, India | |||
| Siflon Drugs and Pharmaceuticals Private Limited | ₹40.38 Cr (FY 2025) | 38.0% | Hyderabad, Telangana, India | |||
| Crescent Labs Private Limitedthis company | ₹38.2 Cr (FY 2025) | ₹2.33 Cr | 6.1% | -8.0% | 50 | Mumbai, Maharashtra, India |
| Unim Pharmalab Ltd | ₹38.07 Cr (FY 2025) | 35.0% | Himatnagar, Gujarat, India | |||
| Veko Care Private Limited | ₹37.39 Cr (FY 2024) | 33.0% | Pune, Maharashtra, India |
To see the full peer comparison of Crescent Labs Private Limited, buy the company report.
Auditor
Crescent Labs Private Limited is audited by Yatin C. Shah & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Yatin C. Shah & Associates | FY 2023 | 049549 |
Shareholding
The shareholding of Crescent Labs Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Crescent Labs Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 15 May 2010 | 10223245 | State Bank of India | ₹3.55 Cr | Satisfied |
To see the full charge records of Crescent Labs Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
Crescent Labs Private Limited has 3 court cases on record: 3 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 3 | 0 |
Cases on record (2 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Vadodara, Gujarat | Criminal complaint | Filed against the company by an individual | Disposed |
| District court, SBS Nagar, Punjab | Criminal miscellaneous application | Filed against the company by State of Punjab | Disposed |
To see the full case history of Crescent Labs Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Crescent Labs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Crescent Labs Private Limited has a workforce of 50 employees on its EPFO records as of Apr 07, 2024, across 1 active EPFO establishment.
GST
Crescent Labs has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AADCC6101E1ZD | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Crescent Labs Private Limited, buy the company report.
Recent activity
Crescent Labs Private Limited has 2 board changes on record since 2009: 2 appointments. The latest: Rajendra Kantilal Shah was appointed as Director on 06 Mar 2009.
Frequently asked questions
Crescent Labs is an active private limited company based in Mumbai, Maharashtra, India. The company works in animal pharmaceuticals and healthcare, within the pharma industry. It was incorporated on 06 March 2009 (17+ years old) and is registered under CIN U24100MH2009PTC190787.
Crescent Labs has 2 current directors:
- Vishal Rajendra Shah - Director
- Rajendra Kantilal Shah - Director
The latest financial statements of Crescent Labs on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Crescent Labs is 24AADCC6101E1ZD, registered in Gujarat. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Crescent Labs is U24100MH2009PTC190787. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Crescent Labs has 3 court cases on record: 3 filed against it.
Crescent Labs was incorporated on 06 March 2009, making it 17+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Crescent Labs by revenue are RR Animal Health Care Limited, Natural Living Private Limited, Siflon Drugs and Pharmaceuticals Private Limited, Unim Pharmalab Ltd, Veko Care Private Limited, all in the Pharma industry (Animal Pharma), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Rajendra Kantilal Shah was appointed as Director on 06 Mar 2009. Vishal Rajendra Shah was appointed as Director on 06 Mar 2009.
Yes, Crescent Labs is registered as a small enterprise under Udyam registration (number: UDYAM-MH-19-0036478).
Crescent Labs can be reached through the website vibropharma.com. Its registered office is in Mumbai, Maharashtra, India.

